European Guideline for Imaging in Paediatric and Adolescent Rhabdomyosarcoma - Joint Statement by the European Paediatric Soft Tissue Sarcoma Study Group, the Cooperative Weichteilsarkom Studiengruppe and the Oncology Task Force of the European...

Overview

Journal Pediatr Radiol

Specialty Pediatrics

Date 2021 Jun 17

PMID 34137936

Citations 15

Authors

Roelof van Ewijk

Reineke A Schoot

Monika Sparber-Sauer

Simone A J Ter Horst

Nina Jehanno

Lise Borgwardt

Bart de Keizer

Johannes H M Merks

Alberto De Luca

Kieran McHugh

Thekla von Kalle

Jurgen F Schafer

Rick R van Rijn

Affiliations

Soon will be listed here.

Abstract

Appropriate imaging is essential in the treatment of children and adolescents with rhabdomyosarcoma. For adequate stratification and optimal individualised local treatment utilising surgery and radiotherapy, high-quality imaging is crucial. The paediatric radiologist, therefore, is an essential member of the multi-disciplinary team providing clinical care and research. This manuscript presents the European rhabdomyosarcoma imaging guideline, based on the recently developed guideline of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG) Imaging Committee. This guideline was developed in collaboration between the EpSSG Imaging Committee, the Cooperative Weichteilsarkom Studiengruppe (CWS) Imaging Group, and the Oncology Task Force of the European Society of Paediatric Radiology (ESPR). MRI is recommended, at diagnosis and follow-up, for the evaluation of the primary tumour and its relationship to surrounding tissues, including assessment of neurovascular structures and loco-regional lymphadenopathy. Chest CT along with [F-18]2-fluoro-2-deoxyglucose (FDG) positron emission tomography (PET)/CT or PET/MRI are recommended for the detection and evaluation of loco-regional and distant metastatic disease. Guidance on the estimation of treatment response, optimal long-term follow-up, technical imaging settings and standardised reporting are described. This European imaging guideline outlines the recommendations for imaging in children and adolescents with rhabdomyosarcoma, with the aim to harmonise imaging and to advance patient care.

Citing Articles

Parameningeal Rhabdomyosarcoma: Results of the European Pediatric Soft Tissue Sarcoma Study Group RMS 2005 Study.

Schoot R, Taselaar P, Scarzello G, Kolb F, Coppadoro B, Horst S Head Neck. 2024; 47(3):974-982.

PMID: 39545397 PMC: 11816552. DOI: 10.1002/hed.27994.

Dimensional assessment on baseline MRI of soft-tissue sarcomas: longest diameter, sum and product of diameters, and volume-which is the best measurement method to predict patients' outcomes?.

DAgostino V, Ponti F, Martella C, Miceli M, Sambri A, De Paolis M Radiol Med. 2024; 129(12):1876-1889.

PMID: 39424744 DOI: 10.1007/s11547-024-01895-8.

Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG).

Chisholm J, Mandeville H, Adams M, Minard-Collin V, Rogers T, Kelsey A Cancers (Basel). 2024; 16(5).

PMID: 38473359 PMC: 10931395. DOI: 10.3390/cancers16050998.

Review on Pediatric Malignant Focal Liver Lesions with Imaging Evaluation: Part II.

Dong Y, Cekuolis A, Schreiber-Dietrich D, Augustiniene R, Schwarz S, Moller K Diagnostics (Basel). 2023; 13(24).

PMID: 38132242 PMC: 10743166. DOI: 10.3390/diagnostics13243659.

Clinical characteristics and outcomes for children, adolescents and young adults with "CIC-fused" or "BCOR-rearranged" soft tissue sarcomas: A multi-institutional European retrospective analysis.

Sparber-Sauer M, Corradini N, Affinita M, Milano G, Pierron G, Carton M Cancer Med. 2023; 12(13):14346-14359.

PMID: 37212486 PMC: 10358194. DOI: 10.1002/cam4.6113.

References

Vaarwerk B, Bisogno G, McHugh K, Brisse H, Morosi C, Corradini N . Indeterminate Pulmonary Nodules at Diagnosis in Rhabdomyosarcoma: Are They Clinically Significant? A Report From the European Paediatric Soft Tissue Sarcoma Study Group. J Clin Oncol. 2019; 37(9):723-730. DOI: 10.1200/JCO.18.01535. View

Rosenberg A, Anderson J, Lyden E, Rodeberg D, Wolden S, Kao S . Early response as assessed by anatomic imaging does not predict failure-free survival among patients with Group III rhabdomyosarcoma: a report from the Children's Oncology Group. Eur J Cancer. 2013; 50(4):816-23. PMC: 3944684. DOI: 10.1016/j.ejca.2013.11.031. View

Routh J, Dasgupta R, Chi Y, Shnorhavorian M, Tian J, Walterhouse D . Impact of local control and surgical lymph node evaluation in localized paratesticular rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee. Int J Cancer. 2020; 147(11):3168-3176. PMC: 7751831. DOI: 10.1002/ijc.33143. View

Spijkers S, Staats J, Littooij A, Nievelstein R . Abdominal lymph node size in children at computed tomography. Pediatr Radiol. 2020; 50(9):1263-1270. PMC: 7399684. DOI: 10.1007/s00247-020-04715-z. View

Cieszanowski A, Lisowska A, Dabrowska M, Korczynski P, Zukowska M, Grudzinski I . MR Imaging of Pulmonary Nodules: Detection Rate and Accuracy of Size Estimation in Comparison to Computed Tomography. PLoS One. 2016; 11(6):e0156272. PMC: 4892605. DOI: 10.1371/journal.pone.0156272. View

Burke M, Anderson J, Kao S, Rodeberg D, Qualman S, Wolden S . Assessment of response to induction therapy and its influence on 5-year failure-free survival in group III rhabdomyosarcoma: the Intergroup Rhabdomyosarcoma Study-IV experience--a report from the Soft Tissue Sarcoma Committee of the Children's.... J Clin Oncol. 2007; 25(31):4909-13. DOI: 10.1200/JCO.2006.10.4257. View

Partridge S, Zhang Z, Newitt D, Gibbs J, Chenevert T, Rosen M . Diffusion-weighted MRI Findings Predict Pathologic Response in Neoadjuvant Treatment of Breast Cancer: The ACRIN 6698 Multicenter Trial. Radiology. 2018; 289(3):618-627. PMC: 6283325. DOI: 10.1148/radiol.2018180273. View

Schafer J, Granata C, von Kalle T, Kyncl M, Littooij A, Di Paolo P . Whole-body magnetic resonance imaging in pediatric oncology - recommendations by the Oncology Task Force of the ESPR. Pediatr Radiol. 2020; 50(8):1162-1174. PMC: 7329776. DOI: 10.1007/s00247-020-04683-4. View

Eisenhauer E, Therasse P, Bogaerts J, Schwartz L, Sargent D, Ford R . New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2008; 45(2):228-47. DOI: 10.1016/j.ejca.2008.10.026. View

10.

Welker J, Henshaw R, Jelinek J, Shmookler B, Malawer M . The percutaneous needle biopsy is safe and recommended in the diagnosis of musculoskeletal masses. Cancer. 2001; 89(12):2677-86. DOI: 10.1002/1097-0142(20001215)89:12<2677::aid-cncr22>3.0.co;2-l. View

11.

Brady A, Picado O, Tashiro J, Sola J, Perez E . Lymph Node Sampling and Survival in Child and Adolescent Extremity Soft-Tissue Sarcoma. J Surg Res. 2019; 241:205-214. DOI: 10.1016/j.jss.2019.03.030. View

12.

Rogers T, Minard-Colin V, Cozic N, Jenney M, Merks J, Gallego S . Paratesticular rhabdomyosarcoma in children and adolescents-Outcome and patterns of relapse when utilizing a nonsurgical strategy for lymph node staging: Report from the International Society of Paediatric Oncology (SIOP) Malignant Mesenchymal.... Pediatr Blood Cancer. 2017; 64(9). DOI: 10.1002/pbc.26486. View

13.

Scheer M, Dantonello T, Brossart P, Dilloo D, Schweigerer L, Feuchtgruber S . Importance of whole-body imaging with complete coverage of hands and feet in alveolar rhabdomyosarcoma staging. Pediatr Radiol. 2018; 48(5):648-657. DOI: 10.1007/s00247-017-4066-8. View

14.

Lin J, Guillerman R, Russell H, Lupo P, Nicholls L, Okcu M . Does Routine Imaging of Patients for Progression or Relapse Improve Survival in Rhabdomyosarcoma?. Pediatr Blood Cancer. 2015; 63(2):202-5. DOI: 10.1002/pbc.25750. View

15.

Ward E, DeSantis C, Robbins A, Kohler B, Jemal A . Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014; 64(2):83-103. DOI: 10.3322/caac.21219. View

16.

Hamilton E, Miller 3rd C, Joseph M, Huh W, Hayes-Jordan A, Austin M . Retroperitoneal lymph node staging in paratesticular rhabdomyosarcoma-are we meeting expectations?. J Surg Res. 2018; 224:44-49. DOI: 10.1016/j.jss.2017.11.051. View

17.

Gallego S, Zanetti I, Orbach D, Ranchere D, Shipley J, Zin A . Fusion status in patients with lymph node-positive (N1) alveolar rhabdomyosarcoma is a powerful predictor of prognosis: Experience of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG). Cancer. 2018; 124(15):3201-3209. DOI: 10.1002/cncr.31553. View

18.

DallIgna P, De Corti F, Alaggio R, Cecchetto G . Sentinel node biopsy in pediatric patients: the experience in a single institution. Eur J Pediatr Surg. 2014; 24(6):482-7. DOI: 10.1055/s-0034-1396422. View

19.

Jabeen N, Qureshi R, Sattar A, Baloch M . Diagnostic Accuracy of Maximum Intensity Projection in Diagnosis of Malignant Pulmonary Nodules. Cureus. 2019; 11(11):e6120. PMC: 6903899. DOI: 10.7759/cureus.6120. View

20.

Hirsch F, Sorge I, Vogel-Claussen J, Roth C, Grafe D, Pats A . The current status and further prospects for lung magnetic resonance imaging in pediatric radiology. Pediatr Radiol. 2020; 50(5):734-749. PMC: 7150663. DOI: 10.1007/s00247-019-04594-z. View